These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22844557)

  • 21. The role of intestinal mast cell infiltration in irritable bowel syndrome.
    Cheng L; Luo QQ; Chen SL
    J Dig Dis; 2021 Mar; 22(3):143-151. PubMed ID: 33511763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome.
    Sundin J; Nordlander S; Eutamene H; Alquier-Bacquie V; Cartier C; Theodorou V; Le Nevé B; Törnblom H; Simrén M; Öhman L
    Neurogastroenterol Motil; 2019 Nov; 31(11):e13701. PubMed ID: 31518490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.
    Xu XJ; Zhang YL; Liu L; Pan L; Yao SK
    Aliment Pharmacol Ther; 2017 Jan; 45(1):100-114. PubMed ID: 27862119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.
    Camilleri M; Lasch K; Zhou W
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G775-85. PubMed ID: 22837345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.
    Tsang SW; Auyeung KK; Bian ZX; Ko JK
    Curr Neuropharmacol; 2016; 14(8):842-856. PubMed ID: 27009115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.
    Wilcz-Villega EM; McClean S; O'Sullivan MA
    Am J Gastroenterol; 2013 Jul; 108(7):1140-51. PubMed ID: 23588236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome].
    Piche T
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S40-7. PubMed ID: 19303538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier.
    Barbara G; Barbaro MR; Fuschi D; Palombo M; Falangone F; Cremon C; Marasco G; Stanghellini V
    Front Nutr; 2021; 8():718356. PubMed ID: 34589512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.
    Martínez C; Rodiño-Janeiro BK; Lobo B; Stanifer ML; Klaus B; Granzow M; González-Castro AM; Salvo-Romero E; Alonso-Cotoner C; Pigrau M; Roeth R; Rappold G; Huber W; González-Silos R; Lorenzo J; de Torres I; Azpiroz F; Boulant S; Vicario M; Niesler B; Santos J
    Gut; 2017 Sep; 66(9):1537-1538. PubMed ID: 28082316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The pathophysiology of irritable bowel syndrome: inflammation and motor disorder].
    Park H
    Korean J Gastroenterol; 2006 Feb; 47(2):101-10. PubMed ID: 16498275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome.
    Chatoo M; Li Y; Ma Z; Coote J; Du J; Chen X
    Front Endocrinol (Lausanne); 2018; 9():21. PubMed ID: 29483895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms.
    Deiteren A; de Wit A; van der Linden L; De Man JG; Pelckmans PA; De Winter BY
    Acta Gastroenterol Belg; 2016 Mar; 79(1):29-38. PubMed ID: 26852761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential neuro-immune therapeutic targets in irritable bowel syndrome.
    Casado-Bedmar M; Keita ÅV
    Therap Adv Gastroenterol; 2020; 13():1756284820910630. PubMed ID: 32313554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3).
    Lacy BE; Rosenbaum D; Edelstein S; Kozuka K; Williams LA; Kunkel DC
    Clin Exp Gastroenterol; 2024; 17():173-183. PubMed ID: 38860153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.
    Dothel G; Barbaro MR; Boudin H; Vasina V; Cremon C; Gargano L; Bellacosa L; De Giorgio R; Le Berre-Scoul C; Aubert P; Neunlist M; De Ponti F; Stanghellini V; Barbara G
    Gastroenterology; 2015 May; 148(5):1002-1011.e4. PubMed ID: 25655556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irritable bowel syndrome: the role of the intestinal microbiota, pathogenesis and therapeutic targets.
    Dahlqvist G; Piessevaux H
    Acta Gastroenterol Belg; 2011 Sep; 74(3):375-80. PubMed ID: 22103040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of miRNA-29a regulates intestinal barrier function in diarrhea-predominant irritable bowel syndrome by upregulating ZO-1 and CLDN1.
    Zhu H; Xiao X; Shi Y; Wu Y; Huang Y; Li D; Xiong F; He G; Chai Y; Tang H
    Exp Ther Med; 2020 Dec; 20(6):155. PubMed ID: 33093893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype.
    Belmonte L; Beutheu Youmba S; Bertiaux-Vandaële N; Antonietti M; Lecleire S; Zalar A; Gourcerol G; Leroi AM; Déchelotte P; Coëffier M; Ducrotté P
    PLoS One; 2012; 7(8):e42777. PubMed ID: 23028414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.